- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05294939
Efficacy of Acute Intake of Ketones on Performance in Professional Road Cyclists (KETA)
Randomized Clinical Trial to Analyze the Efficacy of Acute Intake of a Ketone Supplement on Performance in Professional Cross-country Road Cyclists
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Subjects who meet the selection criteria will be randomly assigned to each of the study groups (investigational product or placebo, depending on the group to which they have been assigned). On the second day, participants will consume the product that subjects did not consume on the first day.
The product to be consumed will be ketone monoester. Participants will consume 800 mg/kg body weight, distributed in two intakes. The first one, half an hour before exercise and the same dose will be consumed one hour and a half after the first dose. The intakes will be accompanied by carbohydrates and bicarbonate.
The tests that the cyclists will perform are a time trial on a cycloergometer to measure performance, as well as a 30" sprint. Afterwards, the cyclists will do a 4 and a half hour training session at competition pace. After this training session, the participants will do the same time trial and the 30'' sprint.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Murcia, Spain, 30107
- Catholic University of Murcia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male professional cyclists.
- Start the study with previous rest.
Exclusion Criteria:
- Participant suffering from chronic illness.
- Suffering a long-term injury that prevents her from training in the month prior to the intervention.
- Inability to understand the informed consent.
- Having consumed ketone bodies chronically in the previous four weeks.
- To have undergone cholecystectomy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Ketone monoester
Consumption of 800mg/kg body weight of ketone monoester, divided in two intakes.
The mixture will be prepared with bicarbonate.
In addition, every hour they should consume 90g of carbohydrates.
|
Consumption of 800mg/kg body weight of ketone monoester, divided in two intakes.
The mixture will be prepared with bicarbonate.
In addition, every hour they should consume 90g of carbohydrates.
|
|
Placebo Comparator: Control product
Consumption of placebo product (carbohydrates) masked with citric, divided in two intakes.
The mixture will be prepared with bicarbonate.
In addition, every hour they should consume 90g of carbohydrates.
|
Consumption of placebo product (carbohydrates) masked with citric, divided in two intakes.
The mixture will be prepared with bicarbonate.
In addition, 90g of carbohydrates should be consumed every hour.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical performance
Time Frame: Change in performance after product consumption and training at a competitive level
|
Measured using a power roller.
Variables such as maximum power and average power
|
Change in performance after product consumption and training at a competitive level
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart Rate
Time Frame: It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
Measured by a chest strap
|
It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
|
Microcapillary blood
Time Frame: It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
This test provides biochemical variables (ABL90FLEX) with 70 ml of capillary blood.
|
It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
|
Lactate
Time Frame: It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
Lactate levels will be measured using the Lactate Pro
|
It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
|
Ketone
Time Frame: It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
Will be measured by the FreeStyle Optium
|
It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
|
Blood glucose
Time Frame: It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
Will be measured by the FreeStyle Optium
|
It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
|
Blood glucose
Time Frame: It will be measured on a daily basis. Measurements will begin two days before the first performance test and end one day after the completion of the performance tests.
|
It will be measured continuously by Supersapiens.
|
It will be measured on a daily basis. Measurements will begin two days before the first performance test and end one day after the completion of the performance tests.
|
|
Heart rate variability
Time Frame: It will be measured every morning. Measurements will be started two days before the first performance test and finished one day after the end of the performance tests.
|
It will be measured for 5 minutes upon awakening.
|
It will be measured every morning. Measurements will be started two days before the first performance test and finished one day after the end of the performance tests.
|
|
Stomach test
Time Frame: It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
It will be measured by means of a visual analog scale from 0 to 10 to determine the annoyance produced by the product (0: none and 10: maximum annoyance).
|
It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
|
Fatigue
Time Frame: It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
Rate of perceived exertion
|
It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UCAMCFE-00022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ketosis
-
University of OklahomaNot yet recruitingExogenous KetosisUnited States
-
University of Alabama at BirminghamCompletedExogenous KetosisUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...American Ketone LLCRecruitingEvaluation of the Safety and Tolerability of Exogenous Ketosis Induced by Free Beta-hydroxybutyrate.Exogenous KetosisMexico
-
University of OxfordCompleted
-
University Health Network, TorontoRecruiting
-
University of AarhusCompleted
-
Montefiore Medical CenterGlenn Foundation for Medical ResearchWithdrawnFasting | Aging Well | Autophagy | Ketosis, MetabolicUnited States
-
University of British ColumbiaRecruitingImmune Functions | Histone Deacetylase (HDAC) Activity | Ketosis, MetabolicCanada
-
Nova BiomedicalOcean Wellness CenterCompletedDiabetes Mellitus | Ketosis, DiabeticUnited States, Germany
-
Baylor College of MedicineCompleted
Clinical Trials on Ketone monoester
-
University of British ColumbiaCompletedOverweight and Obesity | Hyperglycemia, Postprandial | Diabetes Mellitus RiskCanada
-
University of British ColumbiaRecruitingImmune Functions | Histone Deacetylase (HDAC) Activity | Ketosis, MetabolicCanada
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Institute for Clinical and Experimental MedicineRecruitingHeart Failure | Cardiogenic Shock | Acute Heart Failure (AHF) | Ketones | Ketone Body MetabolismCzechia
-
McMaster UniversityCompleted
-
University of British ColumbiaCompleted
-
McMaster UniversityCompleted
-
University of British ColumbiaCompletedDietary Supplement: Ketone Supplement | Dietary Supplement: PlaceboCanada
-
University of British ColumbiaCompleted
-
University of AarhusCompleted